Royal Bank of Canada’s Nanobiotix NBTX Stock Holding History

Royal Bank of Canada’s Portfolio NBTX Stock Details NBTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$56K	Sell	1,825 -800	-30%	-$21.1K	﹤0.01%	5441
2025 Q4	$61K	Buy	2,625 +2,500	+2,000%	+$54.6K	﹤0.01%	5458
2025 Q3	$2K	Hold	125	–	–	﹤0.01%	6892
2025 Q2	$1K	Sell	125 -11	-8%	-$43	﹤0.01%	6909
2025 Q1	$0	Buy	136 +7	+5%	+$24	﹤0.01%	7092
2024 Q4	$0	Buy	+129	New	+$516	﹤0.01%	7119
2024 Q3	–	Sell	-263	Closed	-$1K	–	7224
2024 Q2	$1K	Buy	263 +229	+674%	+$1.38K	﹤0.01%	6861
2024 Q1	$0	Sell	34 -271	-89%	-$1.92K	﹤0.01%	7386
2023 Q4	$2K	Buy	+305	New	+$1.93K	﹤0.01%	6822

Other funds holding NBTX

Johnson & Johnson New Brunswick, New Jersey $799M AUM 253.51% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Optiver Holding Amsterdam, Netherlands $289B AUM 33.63% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return

GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return

EWA

EverSource Wealth Advisors Birmingham, Alabama $2.97B AUM 28.72% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Royal Bank of Canada's NBTX Position: Q1 2026 in Review

Royal Bank of Canada reduced its Nanobiotix (NBTX) stake by 30% in Q1 2026, selling an estimated $21.1K and leaving 1,825 shares worth $56K. The position accounts for ﹤0.01% of the portfolio, ranked #5441.

Royal Bank of Canada first reported a position in NBTX in Q4 2023 and has held it in 9 quarters since. The position peaked at $61K in Q4 2025. 15 funds tracked by Wall St. Rank hold NBTX as of Q1 2026.

Royal Bank of Canada held 1,825 shares of Nanobiotix worth $56K as of Q1 2026.
Royal Bank of Canada sold 800 Nanobiotix shares in Q1 2026, an estimated $21.1K.
Nanobiotix made up ﹤0.01% of Royal Bank of Canada's portfolio in Q1 2026, its #5441 holding.
Royal Bank of Canada first reported a position in Nanobiotix in Q4 2023 and has held it in 9 quarters since.
Royal Bank of Canada's Nanobiotix position peaked at $61K in Q4 2025.
15 funds tracked by Wall St. Rank held Nanobiotix as of Q1 2026.

Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.